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Abstract
Upper airway diseases decrease sleep time and/or quality, which leads to excessive day 
time sleepiness, fatigue, and lack of concentration. Upper airway diseases can be classi-
fied into two groups: upper airway resistance syndrome and sleep apnea syndrome. Sleep 
apnea syndrome is a disease, which occurs during sleeping, characterized by apneic and 
hypopneic events, low oxygen levels in lungs, blood oxygen desaturation, sleep arousal, 
and/or awakening. It increases morbidity and mortality of the patients. Sleep apnea syn-
drome has three types: central, mixed, and obstructive. Central and mixed apnea can be 
treated only by medical practitioners. But in the treatment of obstructive sleep apnea, 
orthodontists and maxillofacial surgeons have an important role. The aim of this chapter 
is to present current information about etiology, diagnostic tools, and treatment alterna-
tives of obstructive sleep apnea and to introduce dental sleep medicine to orthodontists.
Keywords: dental sleep medicine, obstructive sleep apnea, dental treatment approaches 
for obstructive sleep apnea, pediatric obstructive sleep apnea
1. Introduction
Sleep-related breathing disorders are pathological changes in respiratory pattern during 
sleep. They increase morbidity and mortality, decreasing the life quality of patients. The 
patients complaining about waking up restless and headache, daytime sleepiness, lack of con-
centration, emotional changes, and unbalanced blood pressure may probably have a secret 
sleep-related breathing disorder.
Dental sleep medicine is an area of dental practice that focuses on dental therapy to treat 
sleep-disordered breathing, including snoring and obstructive sleep apnea. Dentists who are 
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specialized in dental sleep medicine can diagnose the early signs and symptoms of potential 
obstructive sleep apnea.
2. Upper airway diseases
Upper airway diseases decrease sleep time and/or quality, which leads to excessive daytime 
sleepiness, fatigue, and lack of concentration. Upper airway diseases can be classified into two 
groups: upper airway resistance syndrome and sleep apnea syndrome.
Snoring is the most evident symptom of these syndromes, but it is not a disease. Snoring is 
just a sound resulting from soft tissues in the upper airway vibrating during inspiration, due 
to the increased velocity of air, caused by the decrease in size of airway space. Almost all 
patients with upper airway resistance syndrome and sleep apnea syndrome snore. However, 
snoring patients may or may not also have sleep apnea or upper airway resistance syndromes. 
Prevalence of snoring is estimated in 35–40% of the population. Snoring is a sign that some 
type of resistance is occurring in the upper respiratory system.
Upper airway resistance syndrome (UARS) occurs when resistance of upper respiratory sys-
tem increases and breathing effort crosses over from harmless snoring. The transformation 
of snoring to UARS can be caused by aging (muscle tone in the throat decreases in time) and 
weight gain. In upper airway resistance syndrome, breathing needs much effort due to the 
narrow upper airway, and this extra effort leads to sleep arousal, frequent nocturnal awak-
enings, chronic insomnia, and excessive daytime sleepiness. Apnea and hypopnea are not 
symptoms of this disease.
UARS and obstructive sleep apnea syndrome (OSAS) have similar etiologies and symptoms, 
so differential diagnosis is very important. The key differences between UARS and OSAS 
consist of apnea-hypopnea existence, gender, and weight differences. In UARS apnea and 
hypopnea are either absent or very low. UARS patients are often in average weight, but OSAS 
patients are generally overweight or obese. UARS affects two genders equally, but OSAS 
affects men more than women.
UARS treatment consists of behavior and lifestyle changes, oral-dental appliances, and con-
tinuous positive airway pressure (CPAP) therapy. When UARS is untreated or treatment is 
unsuccessful, it can end up developing sleep apnea syndrome.
Sleep apnea syndrome is a chronic, progressive, and life-threatening disorder which occurs 
during sleeping and characterized by apneic and hypopneic events, hypoxia, blood oxygen 
desaturation, sleep arousal, and/or awakening. Sleep apnea has three types: central, obstruc-
tive, and mixed. In central apnea respiratory muscles need extra effort because breathing is 
limited or completely blocked due to the obstruction in the upper airway. Mixed apnea is the 
combination of central and obstructive apnea. Central and mixed apnea can be treated only 
by medical practitioners. But in the treatment of obstructive sleep apnea, dentists have an 
important role [1–4].
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3. Obstructive Sleep Apnea Syndrome (OSAS)
Obstructive sleep apnea syndrome is a sleep-related breathing disorder that increases mor-
bidity and mortality in patients, which is characterized by recurrent episodes of partial or 
complete upper airway obstructions and blood oxygen desaturation during sleep. This syn-
drome leads to severe long-term health problems as a result of the decrease in blood pressure 
during apnea and hypopnea episodes. Increased risk of high blood pressure, heart disease, 
heart arrhythmias, heart failure, and stroke can be seen in OSA patients.
OSAS prevalence is estimated at 3–7% in men and 2–5% in women. People from all ages, even 
pediatric and adolescent ages, can be affected from OSAS, but middle ages have the highest 
prevalence.
There are some definitions and indexes in order to define and classify the syndrome:
Apnea is the arousal of breathing for 10 seconds or more. It is a full obstruction of the airway 
when a person is asleep.
Hypopnea is a reduction in ventilation of at least 50% that results in a decrease in arterial 
saturation of 4% or more. It occurs due to partial airway obstruction.
Apnea index (AI) shows the average number of apneas and hypopneas per hour of sleep. The 
term respiratory disturbance index (RDI) can be used instead of AHI.
Arousal is a sudden change from a deeper sleep stage to a superficial sleep stage. It ends up 
in apnea and hypopnea.
Arousal index shows the average number of arousals per hour of sleep.
Minimum oxygen saturation is the minimum oxygen saturation level recorded in the whole 
sleep time [5–9].
4. Pathogenesis of obstructive sleep apnea
Upper airway has a great tendency to obstruction. Any pathological change that narrows the 
airway leads to OSAS. The pharynx is the site of upper airway obstruction during sleep. The size 
of the pharyngeal lumen depends on the balance between the forces that narrows and dilates 
the airway. The force that narrows the upper airway is the suction type, negative air pressure 
occurring during inspiration, and personal anatomical factors. The force that dilates the upper 
airway is the tension of the genioglossus and tensor veli palatini muscles surrounding the 
airway and tension of other small muscles attached to the pharynx. The difference between 
the narrowing and dilating forces are called transmural pressure. During sleep the tension 
of the muscles surrounding the airway decreases. The tongue and soft palate displace to the 
posterior wall of the oropharynx and narrows the upper airway. The airflow rate increases due 
to the narrowing airway dimension. The increased airflow applies more negative, suction-type 
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pressure to the airway lumen. The increased negative airway pressure, decreased muscle activ-
ity, and airway lumen diameter lead to upper airway obstruction and apnea. During apnea the 
blood oxygen desaturation decreases, carbon dioxide saturation increases, and pH decreases. 
This change leads to the stimulation of central nervous system chemoreceptors, and awaken-
ing occurs to end up in apneic process. When the patient awakens, the tension of the muscles 
increases, which ends up in the obstruction of the upper airway. Blood oxygen saturation 
increases, carbon dioxide saturation decreases, pH increases, and the patient falls asleep again. 
This sleeping, apnea, awakening cycle continues during total sleep time [3, 5, 6, 8].
5. Etiology of obstructive sleep apnea
The etiology of OSAS is multifaceted. The factors that lead to OSA can change in adults and 
pediatric and adolescent patients.
5.1. Adult OSAS etiology
General factors: Age, gender, obesity, alcohol consumption, sedative medicine consumption.
Anatomical factors: Lesions and anatomical variations, nasal obstruction, neck circumference, 
head and neck position, airway shape, and dimension.
Mechanical factors: Supine position, upper airway resistance, upper airway compliance, 
intraluminal pressure, extraluminal pressure, thoracic caudal traction, mucosal adhesive 
affects, vascular factors.
Neuromuscular factors: Upper airway dilator muscles, upper airway reflexes, dilator muscle, 
and diaphragm relations.
Central factors: Hypocapnic apneic threshold, periodical breathing, arousal, and cytokines.
5.2. General factors
1. Age: OSA can be seen in all ages but mostly seen in middle ages. The tissue elasticity, 
ventilation on central, and pulmonary and cardiovascular functions decrease with age, 
and those factors lead to OSAS.
2. Gender: Men are affected more than women because of testosterone hormone inhibits res-
piration and men have more pharyngeal and supraglottic airway resistance than women.
3. Obesity: There is a close correlation between obesity and apnea. Obese patients have more 
fat deposits around soft palate. The fat infiltration from lateral to upper airway decreases 
the airway area and leads to apnea.
4. Alcohol and sedative medicine consumption: Investigations indicate that the activity of 
genioglossus and tensor veli palatini muscles decreases when the patient is asleep in a 
supine position. Alcohol and sedative medicine consumption can exaggerate this condi-
tion; the airway area decreases leading to apnea.
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5.3. Anatomical factors
1. Lesions and anatomical variations: Changes in craniofacial form, inadequate muscle 
activity, soft tissue anomalies, micrognathia, retrognathia, macroglossia, enlarged soft 
palate, steep mandibular plane angle, nasal obstruction, adenotonsillar hypertrophy, 
reduced airway lumen, vocal cord dysfunction, edema of the epiglottis, polyps, tumors, 
acromegaly, nasal obstruction, juvenile temporomandibular ankylosis, and syndromes 
(Franceschetti-Treacher Collins, Apert, Crouzon, Pierre Robin, and Down syndromes) 
may cause OSA.
2. Neck circumference: Neck circumference is a significant predictor of OSA. Men and 
women have a greater risk for OSA if they have neck circumferences of 17 and 16 inch or 
greater, respectively.
3. Head and neck position: When a patient changes from upright to supine position, the thick-
ness of the soft palate increases, and the anteroposterior oropharyngeal cross- sectional 
area decreases. The decrease in cross-sectional area is most evident in posterior of the soft 
palate.
4. Airway lumen diameter and shape: The investigations have shown that the OSAS patients 
have narrower airway area even they are awake and upright position. The airway has an 
anteroposterior configuration in normal people, but OSAS patients’ airway has horizontal 
configuration [1–12].
6. Symptoms of obstructive sleep apnea
Major symptoms: Snoring, apnea, excessive daytime sleepiness.
Cardiopulmonary symptoms: Systemic hypertension, pulmonary hypertension, nocturnal 
arrhythmia, atypical breath ache, acute pulmonary edema, reversible proteinuria.
Neurobehavioral and social: Restlessness and headache in the morning, insomnia, depres-
sion, anxiety, mood disturbances, tendency to accidents, nervousness, forgetfulness.
Other symptoms: Dry mouth, night transpiration, nocturnal cough, hearing loss, gastro-
esophageal reflux [1–21].
7. Classification of OSAS
The severity of OSAS can be classified into three groups according to the apnea-hypopnea 
index (AHI). An AHI score smaller than 5 is considered normal. An AHI score between 10 and 
20 represents mild obstructive sleep apnea, AHI score of 21–40 represents moderate obstruc-
tive sleep apnea, and AHI score greater than 40 represents severe obstructive sleep apnea 
[10–12, 22].
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8. Diagnostic methods of OSAS
OSAS is a life-threatening syndrome which affects cardiovascular, pulmonary, psychologi-
cal, and neurological systems. Because of this reason, the diagnosis and treatment plan of 
this syndrome should be done by a multidisciplinary team. The team should consist of 
medical practitioners, sleep specialists, psychiatrists, and dentists. The diagnosis and treat-
ment plan should be done after a comprehensive medical and dental history and examina-
tion [10, 12, 13, 22].






a. Nose-ear-throat and head-neck inspection: Inspection of the tonsil, soft palate, and tongue; 
inspection of maxillofacial characteristics; inspection of craniofacial characteristics, neck 
circumference, and natural head position.
b. Dental inspection: Malocclusion, maxillar and mandibular deficiency, narrow maxilla and 
maxillar segment, and dry mouth.
c. Systemic examination: Weight and inspection of pulmonary, cardiac, and neurobehavio-
ral functions.
8.2. Endoscopic examination
Endoscopic examination is frequently used for the inspection of upper airway from the nose 
to the glottis. The dynamic upper airway changes and the level of collapse in upper airway 
can be seen in this method. Especially before surgical treatments, the level and severity of 
collapse can be seen, and the operation can be planned according to these data.
8.3. Polysomnography (PSG)
Nocturnal, laboratory-based polysomnography is the gold standard diagnostic tool for obstruc-
tive sleep apnea syndrome. It is used for diagnosing, determining the severity of disease, and 
evaluating various other sleep disorders that can exist with or without OSAS. It is also used 
after OSAS treatment for the evaluation of the treatment effectiveness. A classical PSG con-
sists of electroencephalogram (EEG), electromyogram (EMG), and electrooculogram (EOG) 
records. PSG measures sleep cycles and stages by recording airflow in and out of lungs during 
breathing, the level of oxygen in blood, breathing effort and rate, brain waves, electrical activ-
ity of muscles, eye movements, and heart rate. The most important parameters measured by 
PSG are apnea index (AI), hypopnea index (HI), apnea-hypopnea index (AHI), and minimum 
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oxygen desaturation. PSG can be done either at a sleep center or in the patients at home. But 
home-based PSG records do not have the same reliability as sleep center-based PSG records.
8.4. Radiological inspection
Upper airway imaging should be performed in OSAS patients in order to examine the anat-
omy of the pharynx, surrounding the craniofacial and soft tissue structures. Lateral cepha-
lometry, computerized tomography (CT), and MR imaging (MRI) are the most commonly 
used radiological inspection methods of OSAS.
8.4.1. Lateral cephalometry
It is the most commonly used radiological inspection method of OSAS. It allows to investigate the 
sagittal and vertical positions of the maxilla and mandible according to the cranial base, maxil-
lomandibular relationships, the sagittal and vertical position of hyoid bone, soft palate anatomy, 
and head posture. It is cheap and noninvasive but documentation can be done in two dimensions.
Cephalometric analysis alone is insufficient to diagnose OSAS. But some cephalometric 
parameters can accept a signal for OSAS risk. Increased mandibular plane angle, steep occlu-
sal plane, over-erupted posterior dentition, large gonial angle, anterior open bite, adipose 
tissue placed in the submental and parapharyngeal region, larger and wider soft palate, and 
increased linear distance from the mandibular plane to the hyoid bone (a distance bigger than 
15.4 mm) create OSA risk [10, 13].
8.4.2. Computed tomography (CT)
The high-resolution and three-dimensional evaluation of the skeletal system and soft tissues 
in maxillofacial complex can be performed by computed tomography. CT imaging is done in 
supine position and can give us the opportunity of recording the changes in upper airway cross-
sectional area in different phases of respiration and predicting the collapse area in OSAS patients. 
The disadvantages of this technique are as follows: being expensive, high radiation level, and the 
low-resolution images of fat tissues around upper airway according to MR imaging [14].
8.4.3. Magnetic resonance imaging (MRI)
Magnetic resonance imaging allows 3D imaging and accurate measurement of the upper 
airway, soft tissues, and skeletal structures. MRI is performed in supine position, it allows 
high-resolution visualization of soft tissues and fat deposits around pharyngeal airway, and 
the volume and area of the airway can be measured accurately. With ultrafast mode dynamic 
observation can be done. But it is expensive and cannot be used in patients who have claus-
trophobia, ferromagnetic clips, or pacemaker [15].
9. Treatment of adult obstructive sleep apnea syndrome
OSAS is a life-threatening disease. Because of this reason, early, accurate, and individualized 
treatment should be performed by a multidisciplinary team. The aim of OSAS treatment is 
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to decrease the number of obstructive episodes and severity and the collapse tendency and 
increase the airway area, blood oxygen saturation, and life quality.
Treatment options in OSAS are:
1. Behavioral modification
2. Surgical treatments
3. Use of nasal continuous positive airway pressure device (nCPAP)
4. Use of oral appliances
9.1. Behavioral modification
Weight loss, quitting smoking and alcohol, changing sleep positions and head posture, and 
avoidance of central nervous system depressors may be beneficial for some patients. Weight 
loss may decrease OSA symptoms by reducing the size of the tongue and soft palate. Quitting 
alcohol and depressor drugs prevents the relaxation of upper airway muscles. Alteration of 
sleeping position can prevent the tongue and mandible moving backward and narrowing the 
airway. The patients are instructed to sleep on their sides rather than their backs.
9.2. Surgical treatment
OSA resulted from anatomic obstruction of the upper airway, unsuccessful behavioral thera-
pies, and inability to tolerate CPAP or oral appliances, which are inclusion criteria for surgical 
treatment. Tracheostomy, tonsillectomy and adenoidectomy, genial advancement with or 
without hyoid myotomy, uvulopalatopharyngoplasty, laser glossectomy and lingualplasty, 
maxillomandibular advancement, and epiglottoplasty are the surgical techniques used for 
the treatment of OSAS.
9.3. Nasal continuous positive airway pressure (nCPAP) device treatment
It is a device which has a small air pump connected to either a sealed face or nose mask. The 
device opens the pharyngeal airway and prevents the soft tissues from collapsing and block-
ing the airway. It is the gold standard treatment option for moderate to severe OSAS cases, 
and the success rate is about 75%. However, patient compliance is poor because of the pump 
noise, the irritation of nasal mucosa because of the airflow to the nose, xerostomia, and poor 
retention. The patient non-compliance ratio was reported to range from 46 to 83%. The ordi-
nary usage of nCPAP device for 4–6 weeks decreases the volume of the tongue and increases 
the pharyngeal volume. Inclusion criteria for nCPAP therapy are moderate and severe OSAS 
patients with AHI score greater than 20, mild OSAS patients with AHI scores between 10 
and 20 but has excessive daytime sleepiness and cardiopulmonary or cerebrovascular risks, 
anatomical-based OSAS patients whose medical health condition is inappropriate to surgi-
cal treatment, and mild-to-moderate OSA patients who have failed behavioral modification 
therapy and unable to tolerate oral appliances [1–10, 16, 17].
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10. Oral appliance therapy
Oral appliance treatment was first introduced in the 1980s and is a very effective treat-
ment option for mild-to-moderate OSAS and seven patients with severe OSA who can-
not tolerate CPAP or refuse surgical therapy. The American Sleep Disorders Association 
reported that oral appliance therapy is the primary treatment for patients with mild OSA 
and a secondary treatment option for moderate to severe OSA. For severe OSA patients, 
reduction in AHI score occurs, but it cannot turn into the normal range. If the AHI score 
cannot be decreased to 20, long-term health risks will continue. Oral appliances can be 
successful if only they are used after the etiological factors are eliminated. Only obstruc-
tive sleep apnea can be treated with oral devices; they are not indicated for central and 
mixed apneas [10–12, 16–21, 23–32].
10.1. Oral appliance therapy indications
1. Snoring patients
2. Upper airway resistance syndrome
3. Mild OSAS patients who have failed behavioral modification therapy
4. Moderate to severe OSAS patients who refused or failed CPAP therapy or surgery
10.2. Oral appliance therapy contraindications
1. Central or mixed obstructive sleep apnea
2. TMJ diseases
3. Periodontal diseases
4. Insufficient oral hygiene
5. Anatomical based OSAS
11. Types of oral appliances
Oral appliances can be classified into four groups according to their affect mechanisms:
1. Mandibular advancement devices (MADs)
2. Tongue retaining devices (TRDs)
3. Palate lifting appliances (PLA)
4. OPAP appliances (oral appliances + CPAP device)
Contemporary Treatment Approaches to Obstructive Sleep Apnea Syndrome
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12. Mandibular advancement devices (MADs)
MADs were first described by Pierre Robin in 1934 in the treatment of a patient with micro-
gnathia as a modified monobloc in order to reposition the mandible in a more forwarded 
position and open the airway. This advancement makes the attached soft tissues and tongue 
stretch and stabilize; by this way, oro- and hypopharyngeal airways enlarge.
MAD appliances can be divided into several groups: monobloc-style one-piece or twin 
block-style two-piece, available to activation or unavailable to activation, teeth-supported or 
teeth- and tissue-supported, and soft- or hard-materialed. All of these appliances increase the 
distance between soft palate and posterior wall of the pharynx and enlarge the space between 
tongue root and posterior region of the oropharynx.
Tooth- and tissue-supported, soft-materialed, activation-optioned MAD appliances are 
reported to be more successful in OSAS treatment. One-pieced or two-pieced appliance 
design does not affect the treatment success.
MAD-type oral appliances are found the most effective type of oral appliances in OSAS treat-
ment [10–12, 17, 19, 23, 25–30].
12.1. MAD indications
Normal or reduced facial height, patients have at least eight teeth per arch, patients who have 
normal soft palate thickness and normal positioned soft palate, and obese patients.
12.2. MAD contraindications
The patients with thick and enlarged soft palate, periodontal disease, and TMJ problems.
MAD appliance construction:
a. Upper and lower dental impressions are taken.
b. Maximum opening, left and right lateral excursion, and maximum protrusion are measured.
c. The appliance is constructed using a position 75% of the patients’ maximum protrusion. 
Vertical opening amount changes individually. But it is recommended to open the bite at 
least 5 or 6 millimeters.
d. Bite registrations in centric occlusion and advanced position are obtained. A George 
gauge and light-body impression material can be helpful in stabilizing the construction 
bite position.
e. The MAD appliance fabricated from soft acrylic, hard acrylic, silicone-based, or Essix-
based materials according to the type of the chosen appliance.
12.3. MAD treatment mechanism
MADs displace the mandible, suprahyoid, and genioglossus muscles anteriorly. This ante-
rior movement prevents oropharyngeal airway obstruction. The forward and downward 
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displacement of the mandible also decreases the gravitational effect of the tongue in supine 
position and enlarges the velopharynx by stretching the palatoglossal and palatopharyngeal 
arches (Figures 1 and 2).
13. Tongue-retaining devices (TRDs)
Tongue-retaining devices were first described by Cartwright and Samelson in 1982 [28]. During 
sleeping and in supine position, the tongue and all gravity-dependent tissues tend to fall poste-
riorly. With TRDs, the tongue is prevented from dropping posteriorly by suction created when 
the patient forces the tongue into a hollow bulb built into the device. The forward position of the 
tongue increases the volume and decreases the resistance of upper airway. The superiority of 
TRDs over MADs is that they can be used for edentulous patients [10–12, 16, 17, 19, 20, 23, 25, 31].
13.1. TRD indications
Edentulous OSA patients, OSA patients who have TMJ disorders, OSA patients with big ton-
sils and large tongues, OSA patients who have less than six teeth per arch, hypothyroidism, 
and sleep position–related apnea-hypopnea occurrence.
13.2. TRD contraindications
Severe periodontal diseases, bruxism, chronic nasal obstruction, patients who are unable to 
move their tongue anteriorly, and obese OSA patients.
13.3. TRD appliance construction
The TRD appliance can be fabricated from soft copolymer materials by the technician to the 
OSA patient individually, or standard fabricated appliances can be used to the patient.
Figure 1. One-piece, non-activation MAD appliance.
Figure 2. Two-piece, activation-optioned MAD appliance.
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13.3.1. Individualized TRD appliance construction
a. Upper and lower dental impressions are taken.
b. Maximum opening, left and right lateral excursion, and maximum protrusion measured.
c. The appliance is constructed using a position 75% of the patients’ maximum protrusion. 
Vertical opening amount differs patient to patient, but it is more than MAD vertical open-
ing amount, in order to place the hollow bulb part.
d. The appliance is fabricated from soft copolymer material like a monobloc with a hollow 
bulb part to place the tongue.
13.3.2. Fabricated TRD appliance construction
a. The tongue is measured by wrapping a piece of dental floss around the tongue. Then, the 
floss is removed and measured.
b. The fabrication appliances have two types, edentulous and dentulous, and three sizes, 
small, medium, and large.
c. The correct type and size are chosen for the patient.
d. The bulb appliance is moistened and compressed and the tongue is inserted.
TRD-type appliances are found to be effective in mild to moderate OSA treatment. They 
decrease AI, HI, AHI, oxygen desaturation, and excessive daytime sleepiness and increase 
minimum oxygen desaturation and genioglossus muscle activity. But the patient compliance 
is low with TRDs because of the irritation in the tongue, hypersalivation, uncomfortable feel-
ing, and non-esthetic appearance.
14. Palate lifting appliances (PLA)
They are used in patients who have a thick and enlarged soft palate. The appliance supports 
and stabilizes the soft palate, prevents soft palate blocking the airway, and reduces the vibra-
tion of soft palate leading to snoring. But they are uncomfortable appliances and the patient 
compliance rates are very low. Because of this reason, they are not frequently used in OSA 
treatment [10, 11].
15. OPAP appliances (oral appliance + CPAP device)
nCPAP device applies very high pressure and high airflow rate which leads to irritation of 
nasal, oral, and throat mucosa and decreases patient compliance. When MAD-type oral appli-
ances are combined with CPAP device, the pressure given by nCPAP diminishes; irritation 
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of nasal, oral, and throat mucosa decreases; and patient compliance and treatment success 
increase. The adaptation of CPAP and MAD appliance should be done by a dental sleep spe-
cialist [10, 18].
16. Side effects of oral appliance therapy
There are very few side effects of oral appliances when compared to other treatment alterna-
tives. Researches have reported that patients prefer treatment with an OA over surgery or 
CPAP appliance, and compliance with OA has been reported to be 40–80%.
The side effects of OA therapy can be divided into two groups:
1. Short-term side effects of OA therapy: Excessive salivation or dry mouth, TMJ sounds and/
or TMJ pain, tooth pain, odd bite feeling in the morning, gum irritation, tenderness in mas-
ticatory muscles, or myofascial pain. These complications are generally mild and transient 
[10, 11, 19, 20].
2. Long-term side effects of OA therapy: OA therapy for OSAS patients is a lifelong treatment. 
Skeletal, dental, and occlusal changes can occur from OA therapy in 2 or more years’ time. 
Craniofacial changes related to long-term oral appliance use can be determined with ceph-
alometric investigations. Skeletal changes generally occur after average treatment duration 
of 5 years. The changes can be summarized as more downward and forward position of the 
mandible, increased lower facial height, decreased overbite and overjet, retroclination of 
the maxillary incisors, proclination of the mandibular incisors, changes in molar relation-
ship, and curve of Spee flattening. Long-term use of OA also makes differences in upper 
airway configuration. Palatal length decreases and pharyngeal area increases in time. These 
changes can be due to the loss of edema caused by snoring and repetitive apneas [10, 32–38].
17. Efficacy and success of oral appliance therapy
OA therapy is an effective and safe long-term therapy for patients with snoring, mild to mod-
erate OSAS. However, the efficiency varies on many factors including the type of OA, mate-
rials used for fabrication, piece number of appliance (monobloc or bibloc), titration ability 
(titrable or untitrable), and degree of sagittal and vertical mandibular displacement.
The efficacy criteria of oral appliance therapy in OSA are:
a. Positive changes in PSG test: Decrease in AHI, AI, HI, arousal score, increase in blood 
oxygen saturation, sleep time, and efficiency
b. Positive subjective feedback of patients: Decrease or quitting snoring and decrease in day-
time sleepiness
c. Enlargement of pharyngeal airway area [10–12, 25, 28, 31, 32]




1. MADs are reported more effective than other types of OAs.
2. Monobloc-type one-piece and soft-materialed OAs are found to be more efficient in reduc-
ing AHI, AI, and snoring.
3. Forward and downward displacement of the mandible is recommended for enlarge-
ment in pharyngeal airway area. But this displacement amount should be assessed 
individually.
4. No definite conclusions can be drawn regarding which type or design of OA has a benefi-
cial influence on subjective treatment efficacy. Individually determination of appliance is 
very important in OA treatment success [10–12, 16, 17, 19, 20, 23, 25–28, 30–32].
18. Intraoral appliance treatment guideline for OSAS patients
The American Sleep Disorders Association (ASDA) has prepared a protocol for OA treatment 
in OSAS patients. A dental sleep specialist should follow up the stages below in the treatment 
of an OSAS patient [21, 24]:
1. Detailed medical and dental history.
2. PSG and medical specialist’s report investigation.
3. Dental investigation: Soft tissue and intraoral inspection, periodontal-occlusal-TMJ inspec-
tion, intraoral habits and parafunction inspection, teeth and restoration inspection, and 
radiological inspection.
4. Upper-lower dental impressions and bite registration are obtained.
5. Selection of OA type for the patient individually. (The success and compliance rate varies 
case to case, and choosing the right type of OA is the most important stage of OA treatment 
protocol.)
6. OA fabrication.
7. Adjustment of the OA. Appliance fit and comfort are controlled, and usage instructions 
are given to patient.
8. Follow-up PSG and lateral cephalogram are taken after appropriate appliance adjustment/
titration and patient adaptation period. Objective determination of the treatment efficiency 
can only be observed by PSG test with the appliance in place. Nearly all patients report 
positive change subjectively; however, they should be proven with PSG reports.
9. If the treatment is found to be effective in the first year of the therapy, four follow-up 
appointments are recommended. After 1 year, two follow-up appointments per year are 
enough. At the follow-up appointments, appliance fit, comfort, effectiveness, and patient 
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compliance are investigated. If the OA is found to be less effective, the titration of OA or 
fabrication of a new OA should be done.
19. Pediatric and adolescent obstructive sleep apnea
Obstructive sleep apnea in pediatric and adolescent patients is characterized by episodic par-
tial or complete upper airway obstruction during sleep. All children with OSAS snore. It has 
been estimated to occur in 5–6% of children. It is most seen in preschool children; the peak age 
is 3–6 years, which coincides with the growth of adenoids and tonsils. Pediatric OSAS is simi-
lar to adult OSAS, but there are differences. Sleep disruption occurred by respiratory pauses 
less than ten seconds. Hypopneic episodes can be seen, usually more than five to ten episodes 
per night with oxygen saturations less than 85%. Pediatric OSAS effects both gender at the 
same ratios, different from adult OSA. Seven percent to nine percent of children snore every 
night; 18% of them snore in nasal, ear, or throat infection periods. The prevalence of pediatric 
OSAS is estimated about 0.5–3%. AHI scores of pediatric sleep apnea is controversial. Some 
protocols of AHI score greater than 1 should be accepted as a pediatric OSA predictor; some 
protocols accepting AHI score greater than 5 is pathognomonic.
19.1. Pediatric and adolescent OSA etiology
Hypertrophic adenoids, hypertrophic tonsils, maxillary transverse deficiency, class 3 maxil-
lary skeletal deficiency, class 2 mandibular skeletal deficiency, overweight and obesity, and 
craniofacial anomalies. (Pierre Robin Sequence, Goldenhar syndrome, Crouzon syndrome, 
Apert syndrome, cleft lip and/or palate, vertical face anomalies, Marfan syndrome, and asso-
ciated 22q deletion syndromes).
19.2. OSA symptoms in children
Abnormal breathing during sleeping, frequent awakenings or restlessness, frequent night-
mares, enuresis, difficult awakening, excessive daytime sleepiness, hyperactivity-behavior 
problems, daytime mouth breathing, poor or irregular sleep patterns, early recognition of 
mouth breathing and airway obstruction; symptoms of recurrent blocked nose; recurrent 
nasal, ear, and throat infections; parents concerned about snoring should alert the dental pro-
fessional for definitive diagnosis for pediatric OSA.
19.3. Differences between pediatric and adult OSA
a. Pediatric OSAS effects both genders equally.
b. Snoring is irregular and interrupted with apneic-hypopneic events in adult OSAS. In pedi-
atric OSAS snoring can be continuous.
c. Daytime sleepiness is mostly seen in adult OSA. In pediatric OSA behavioral changes and 
growth retardation are seen more than daytime sleepiness.
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d. Mouth breathing is mostly seen in pediatric OSA [39–42].
e. Obesity is mostly seen in adult OSA; in pediatric OSA, the patient can be of normal weight 
or thin.
f. The etiology of pediatric OSA is mostly hypertrophic adenoids and tonsils. In adult OSA 
retropharyngeal and retrolingual pathologies are more effective.
g. The gold standard treatment protocol for adult OSA is CPAP appliance. In pediatric OSA 
adenotonsillectomy is advised rather than CPAP therapy.
19.4. Clinical inspection in pediatric sleep apnea syndrome
a. Nose-ear-throat and head-neck inspection: Craniofacial, orofacial, and maxillofacial char-
acteristics are investigated. In craniofacial inspection symptoms of various syndromes are 
investigated. In orofacial inspection features of the tongue, soft palate, and tonsils are 
investigated. In maxillofacial inspection maxillofacial characteristics like facies adenoida-
lis, rhinolalia clausa, long-thin face, narrow maxilla and maxillary segment, overlenght-
ened teeth, hypoplastic mandible, and septum deviation are investigated.
b. Systemic inspection: Includes inspection of pulmonary, cardiac, physical, and mental con-
dition functions and weight.
20. Pediatric OSA treatment protocol
1. Surgical approaches: In pediatric patients dentists should examine oropharynx carefully. 
Both the lingual and pharyngeal tonsils can be visible intraorally, but the adenoids will not. 
When hypertrophic tonsils are observed clinically or radiographically, referral for endo-
scopic evaluation and possible surgical removal by a pediatric otolaryngologist should be 
made. Early removal of these tissues can prevent the long-face growth pattern with narrow 
upper and lower dental arches and anterior open bite.
2. Weight loss and behavioral changes
3. Rapid maxillary expansion (RME): Cephalometric and acoustic rhinometry studies 
report that with RME maxilla, the palate and floor of nasal cavity expand, which leads to 
increase the volume and decrease the airflow resistance in nasal cavity. It also makes sta-
tistically significant changes in tongue size position and hyoid position. The expansion 
in maxillary dentition gives the tongue a greater space and more forward positioning to 
the tongue. The widened maxillary basal bone on the velum, the superior pharyngeal 
constrictor muscles, and the surrounding orofacial musculature can increase the muscle 
tonus.
4. Class 2 growth modification therapy: When the pediatric and adolescent patients have both 
mandibular deficiency and obstructive sleep apnea, mandibular advancement devices like 
Herbst, twin block, monobloc, bionator, Frankel 2, etc. can be used for the treatment.
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5. Class 3 growth modification therapy: When the pediatric or adolescent patients have 
both class 3 maxillary deficiency and OSA, class 3 growth modification therapy is rec-
ommended. In this treatment maxilla is widened first with RPE, followed by orthopedic 
traction with protraction face mask (reverse pull headgear).
6. CPAP therapy: This therapy can be advised to severely affected adolescent OSAS patients. 
In pediatric and adolescent population, the long-term use of CPAP can cause craniofacial 
side effects. The force applied from the elastic strap of CPAP mask applies a restraining 
force on the maxilla. So, CPAP therapy can lead a class 3 skeletal deficiency in pediatric 
and adolescent OSA patients. But it is unclear how much of the malocclusion results from 
CPAP and how much results from an underlying adverse growth pattern.
21. Conclusion
Sleep-related breathing disorders are complicated problems, which decrease life quality and 
increase morbidity and mortality in patients.
Dentists, who are specialized in dental sleep medicine, can see the early symptoms of these 
diseases and can be frontline screeners for potential OSAS diagnosis. In the treatment of snor-
ing and mild-to-moderate obstructive sleep apnea, the oral appliance therapy was found to 
be a very effective treatment option.
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